The short answer: Breast implants approved by the FDA in the United States include products from Motiva, Mentor, Allergan Natrelle and Sientra, in saline and silicone gel fillings. Brand is only one part of the decision. You and your surgeon will also choose the filling, surface, shape, profile, size and placement. The FDA also stresses that breast implants are not lifetime devices, that silicone implants need ongoing screening, and that you should review a patient decision checklist with your surgeon before surgery.
This guide summarizes publicly available FDA information as of November 2026 so you can ask better questions. Approval status can change, so confirm the details with the FDA and your surgeon. Learn more about our breast augmentation consultations and our post on long-term implant decisions.
Which brands and implants are FDA-approved?
According to the FDA’s labeling page for approved breast implants (updated February 2025), approved devices include:
- Saline-filled: Mentor Saline, Allergan (Inamed) Saline, and the Puregraft Serene Saline implant (formerly IDEAL IMPLANT).
- Silicone gel-filled: Mentor MemoryGel and MemoryShape, Allergan Natrelle silicone gel including the Natrelle 410 highly cohesive implant, Sientra OPUS (now owned by Tiger Aesthetics Medical), and Motiva SmoothSilk Round and Ergonomix.
Motiva’s silicone gel implants received FDA approval on September 26, 2024, according to the FDA’s premarket approval database; the indication is breast augmentation in women at least 22 years old, and the labeling page lists three-year core study follow-up. In July 2019 the FDA reported that Allergan voluntarily recalled Natrelle BIOCELL textured implants and tissue expanders; smooth implants were not part of that recall. Availability of specific products can change, so ask which implants a practice offers. The Method currently offers Motiva and Allergan implants, and our team reviews silicone and saline options based on your anatomy, goals and safety considerations during consultation.
The choices you and your surgeon make
- Filling: saline or silicone gel. The FDA notes that silicone gel implants can rupture without symptoms, which is why imaging screening applies. Saline implants deflate visibly if they leak.
- Surface: smooth or textured. The FDA links most reported cases of a rare lymphoma (see below) to textured implants.
- Shape, profile, size and placement: round or anatomical, how far the implant projects, its volume, and whether it sits over or under the muscle. Ask your surgeon how each choice affects your result and your future risk of revision.
What the FDA says about safety
- Boxed warning and checklist: in October 2021 the FDA approved new labeling, including a boxed warning, for all legally marketed breast implants. The FDA also recommends a patient decision checklist that you review with your surgeon and that both of you sign.
- Not lifetime devices: the longer implants stay in, the more likely removal or replacement becomes, and insurance may not cover it.
- Complications: include capsular contracture, rupture, deflation (saline), infection, malposition, and changes in nipple or breast sensation. Some patients report symptoms such as fatigue, memory problems, rash or joint pain; their cause is not well understood.
- Screening: for silicone gel implants, the FDA says MRI is the most effective way to detect silent rupture and ultrasound is an acceptable alternative. Ask your surgeon for the recommended schedule for your specific implant.
What is BIA-ALCL?
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma, not a breast cancer. It is usually treatable, but deaths have been reported. As of June 30, 2024, the FDA had received 1,380 unique case reports, of which 73% involved textured implants, 3% smooth implants and 24% unspecified, with a median of about eight years from implant to diagnosis. The FDA cautions that these are passive reports and cannot show how common the condition is. Persistent swelling, pain or a lump near an implant should be evaluated.
Questions to ask at your consultation
- Which exact implant (brand, filling, surface, shape, profile) do you recommend for me, and why?
- Is it FDA-approved for my age and use, and how long is its study follow-up?
- What are your own complication and reoperation experiences?
- How often and by what method will I be screened, and who pays?
- What will future removal or replacement cost, and does my insurance cover it?
- Will I receive the FDA patient decision checklist and a device ID card?
- What are the signs of BIA-ALCL, and who do I call?
- How might pregnancy, breastfeeding, mammography or aging affect my results?
Frequently asked questions
Which breast implant brand is best?
There is no single best brand for everyone. Sources emphasize choosing an experienced surgeon and discussing the specific implant that fits your anatomy and goals.
Is Motiva FDA-approved?
The FDA’s database lists Motiva SmoothSilk Round and Ergonomix silicone gel implants as approved on September 26, 2024. Confirm current labeling with the FDA.
Do breast implants need to be replaced?
The FDA says implants are not lifetime devices, and removal or replacement becomes more likely over time.
A useful next step
Write down the size, shape and feel you want, then bring these questions to your consultation. To discuss your goals with The Method Plastic Surgery, request a consultation.
Ready to talk? Request a consultation, call us at +1 954-287-1808, or learn about our financing options.
This article is general education, not medical advice or a determination of candidacy. Sources reviewed November 2026: FDA labeling for approved breast implants (February 2025), FDA premarket approval record P230005 (Motiva), FDA breast implants overview, FDA risks and complications of breast implants and FDA medical device reports on BIA-ALCL.